BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9617328)

  • 1. [Adjuvant chemotherapy with UFT or UFT with OK-432 to patients with gastric and colorectal cancer. Kanto Adjuvant Study Group].
    Konishi T; Idezuki Y; Watanabe H; Haga S; Ushirokouji Y; Shinohara K; Shibusawa M; Bandai Y; Hiraishi M; Murata N; Yabe K; Yamamura T; Yumoto S; Gunji A; Nishigaki M
    Gan To Kagaku Ryoho; 1998 May; 25(6):887-900. PubMed ID: 9617328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].
    Takashima S; Tomita F; Saito H; Gotoda H; Kinami Y; Miyazaki I; Yamaguchi A
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2315-24. PubMed ID: 1929450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer].
    Kikkawa N; Kawahara T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1881-5. PubMed ID: 3382240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with UFT as surgical adjuvant chemotherapy in carcinoma of large intestine. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan].
    Kikuchi K; Kunii Y; Kunitomo K
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):663-70. PubMed ID: 2108614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
    Danno M; Shiroto H; Kunii Y; Ishibiki K; Yamamura Y; Sakamoto Y; Tamura Y; Kunitomo K; Kumashiro R;
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):195-203. PubMed ID: 11242646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer.
    Nakagoe T; Ishikawa H; Sawai T; Tuji T; Ayabe H; Eida K; Nogawa T; Nakamura Y; Kunisaki T; Tobinaga K; Furukawa M; Ino M
    Anticancer Res; 2000; 20(2B):1069-75. PubMed ID: 10810399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
    Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
    Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
    Sinmyo K; Hosoi H; Suwa H; Kitagawa M; Yamaguchi K; Susaki H
    Gan To Kagaku Ryoho; 1989 May; 16(5):2051-7. PubMed ID: 2499267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter cooperative study of pre- and post-operative adjuvant chemotherapy in the treatment of colorectal cancer. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Kuroda Y; Arima S; Ohsato K; Ohkuma R; Fukuyama N; Yamanouchi A; Hisatsugu T; Yamamoto H; Nakamura Y; Abe R
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2025-30. PubMed ID: 1417010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
    Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
    Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
    J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer.
    Arima S; Ohsato K; Hisatsugu T; Shimura H
    Eur J Surg; 1994 Apr; 160(4):227-32. PubMed ID: 8049313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): a preliminary report. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan].
    Kodaira S; Kikuchi K; Inokuchi K; Komi N; Hattori T; Taguchi T; Kondo T; Abe O; Uchino J; Ogawa N
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3399-408. PubMed ID: 2508566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
    Oki E; Kakeji Y; Yoshida R; Ikeda K; Nishida K; Koga T; Egashira A; Tokunaga E; Morita M; Baba H; Maehara Y
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():138-43. PubMed ID: 16897990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.